Published in Ann Surg on January 01, 1995
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg (2000) 2.94
Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg (1997) 2.56
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol (2011) 2.38
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06
Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg (2000) 2.00
Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol (2010) 1.82
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg (1996) 1.77
Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg (1998) 1.76
Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer (1999) 1.72
Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford) (2009) 1.67
Photodynamic therapy for cancer of the pancreas. Gut (2002) 1.51
Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study. Ann Surg (2002) 1.48
Treatment of pancreatic cancer: challenge of the facts. World J Surg (2003) 1.45
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. Oncogene (2009) 1.37
The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today (1999) 1.37
Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg (2002) 1.29
Surgical outcome of adenosquamous carcinoma of the pancreas. World J Gastroenterol (2008) 1.27
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol (2007) 1.20
Redefining resection margin status in pancreatic cancer. HPB (Oxford) (2009) 1.12
5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer. J Gastrointest Surg (2005) 1.09
Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association. HPB (Oxford) (2013) 1.08
Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev (2009) 1.08
Quality of life in pancreatic cancer: analysis by stage and treatment. J Gastrointest Surg (2008) 1.07
Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br J Cancer (2005) 1.05
Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg (2007) 1.04
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer. Gut (2005) 1.02
Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer. Pancreas (2009) 1.00
The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford) (2008) 1.00
Anticipation in familial pancreatic cancer. Gut (2005) 1.00
Omental flap in pancreaticoduodenectomy for protection of splanchnic vessels. World J Surg (2005) 1.00
Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas. Surg Today (2000) 0.99
Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial. Surg Today (2008) 0.99
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol (2011) 0.99
Adjuvant therapy in pancreatic cancer. World J Gastroenterol (2001) 0.97
bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells. J Cell Mol Med (2007) 0.95
Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement. Ann Surg (2004) 0.93
Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol (2009) 0.92
Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) (2005) 0.91
Long-term survival and prognostic indicators in small (<or=2 cm) pancreatic cancer. Pancreatology (2008) 0.90
Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle (2013) 0.89
Postoperative complications influence prognosis and recurrence patterns in periampullary cancer. World J Surg (2013) 0.89
Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. Int J Clin Oncol (2007) 0.89
Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol (2013) 0.89
Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg (2009) 0.89
Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford) (2011) 0.89
Risk factors influencing recurrence following resection of pancreatic head cancer. World J Gastroenterol (2004) 0.87
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys (2014) 0.87
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. World J Surg Oncol (2012) 0.87
Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol (2010) 0.87
Improving outcomes for pancreatic cancer: radical surgery with patient-tailored, surgery-specific advanced haemodynamic monitoring. BMJ Case Rep (2013) 0.87
Prognostic factors in periampullary and pancreatic tumor resection in elderly patients. World J Surg (2006) 0.86
Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol (2007) 0.86
Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection. World J Gastroenterol (2009) 0.86
Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) (2006) 0.85
Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence. Radiat Oncol (2010) 0.84
Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy. South Asian J Cancer (2013) 0.84
Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis. World J Gastroenterol (2015) 0.84
Clinical and pathologic prognostic factors for curative resection for pancreatic cancer. HPB (Oxford) (2008) 0.84
Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma. World J Gastrointest Oncol (2012) 0.83
Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides. World J Gastroenterol (2008) 0.83
Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterol Res Pract (2012) 0.82
Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report. World J Surg Oncol (2013) 0.82
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol (2008) 0.82
Long-term survival in patients with pancreatic ductal adenocarcinoma. Surgery (2016) 0.81
Resection of isolated local and metastatic recurrence in periampullary adenocarcinoma. HPB (Oxford) (2013) 0.81
Is perineural invasion more accurate than other factors to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma? World J Surg (2014) 0.81
Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. World J Gastroenterol (2014) 0.79
Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients. J Gastroenterol (2009) 0.79
Evolution of cellular morpho-phenotypes in cancer metastasis. Sci Rep (2015) 0.79
Management of pancreatic adenocarcinoma in Ontario, Canada: a population-based study using novel case ascertainment. Can J Surg (2011) 0.79
Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosis. Arch Med Sci (2014) 0.79
Pancreatic carcinomas smaller than 3.0 cm: endosonography (EUS) in diagnosis, staging and prediction of resectability. HPB (Oxford) (2003) 0.79
How to pass on expertise: pancreatoduodenectomy at a teaching hospital. World J Surg (2002) 0.79
The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Cancer (2013) 0.78
Can pancreaticoduodenectomy performed at a comprehensive community cancer center have comparable results as major tertiary center? J Gastrointest Oncol (2011) 0.78
Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am (2015) 0.78
Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer. PLoS One (2016) 0.78
Vitamin d and pancreatic cancer-an update. Cancers (Basel) (2011) 0.78
Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. Medicine (Baltimore) (2016) 0.77
The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients. HPB (Oxford) (2015) 0.76
Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy. World J Gastroenterol (2006) 0.76
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. Ann Surg Oncol (2016) 0.75
Improving Survival of Pancreatic Cancer. What Have We Learnt? Indian J Surg (2015) 0.75
An audit of pathology lymph node dissection techniques in pylorus preserving Kausch-Whipple pancreatoduodenectomy specimens. J Clin Pathol (2001) 0.75
Clinical impact of preoperative endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma. Endosc Ultrasound (2016) 0.75
Pancreatic adenocarcinoma: why and when should it be resected? Postgrad Med J (1997) 0.75
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford) (2016) 0.75
Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells. Curr Ther Res Clin Exp (2010) 0.75
Transcatheter arterial chemoembolization for hepatic recurrence after curative resection of pancreatic adenocarcinoma. Gut Liver (2010) 0.75
TREATMENT OF CARCINOMA OF THE AMPULLA OF VATER. Ann Surg (1935) 26.74
Pancreatic carcinoma. N Engl J Med (1992) 7.25
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg (1985) 7.14
Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg (1990) 7.04
One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg (1993) 5.87
The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet (1970) 5.59
Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg (1987) 5.58
Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94
Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg (1991) 3.88
Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg (1986) 3.81
The complications of pancreatectomy. Ann Surg (1988) 3.40
Pyloric and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg (1986) 3.26
Cancer of the pancreas. 50 years of surgery. Cancer (1987) 3.13
Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg (1993) 2.15
Surgical experience with pancreatic and periampullary cancer. Ann Surg (1982) 2.09
Considerations that lower pancreatoduodenectomy mortality. Am J Surg (1977) 2.08
Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg (1977) 2.08
Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03
Survival in 1001 patients with carcinoma of the pancreas. Ann Surg (1987) 2.02
Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg (1980) 1.96
Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg (1981) 1.90
Periampullary tumors: which ones should be resected? Am J Surg (1985) 1.85
Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg (1988) 1.83
Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg (1988) 1.74
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71
Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer (1993) 1.66
Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective. World J Surg (1984) 1.61
Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet (1992) 1.55
Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg (1993) 1.43
Cancer of the pancreas: diagnostic accuracy and survival statistics. Cancer (1978) 1.39
Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis. Am J Surg (1987) 1.32
The advantages of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg (1992) 1.31
Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg (1986) 1.27
Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg (1993) 1.23
Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg (1993) 1.21
Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg (1982) 1.15
Pancreatoduodenectomy with pylorus preservation for adenocarcinoma of the head of the pancreas. Br J Surg (1986) 1.13
Carcinoma of the ampulla of Vater. Br J Surg (1986) 1.05
Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer. World J Surg (1993) 1.00
Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study. Eur J Surg Oncol (1993) 0.93
Pancreas cancer -- duct cell adenocarcinoma: survival in relation to site, size, stage and type of therapy. J Surg Oncol (1978) 0.93
The pattern of lymph node involvement in carcinoma of the head of the pancreas. A histologic study of the surgical findings in patients undergoing extensive nodal dissections. Int J Pancreatol (1993) 0.92
The importance of tumour volume in the prognosis of radically treated periampullary carcinomas. Eur J Surg (1993) 0.91
Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis. Int J Pancreatol (1992) 0.86
Long-term survivors after operation on carcinoma of the pancreas. Int J Pancreatol (1988) 0.83
Factors influencing the late results of operation for carcinoma of the pancreas. Am J Surg (1978) 0.83
The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91
Mesenteric venous thrombosis. N Engl J Med (2001) 5.87
Surgical management of intussusception in the adult. Ann Surg (1981) 5.42
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A (1991) 4.61
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med (2001) 4.45
Metastasis to the thyroid gland. A report of 43 cases. Cancer (1997) 4.08
Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06
Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01
Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94
Pulmonary Langerhans'-cell histiocytosis. N Engl J Med (2000) 3.83
Bronchiolitis obliterans organizing pneumonia. N Engl J Med (1985) 3.78
Adenocarcinoma of the stomach: are we making progress? Lancet (1993) 3.68
Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19
Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med (2001) 2.94
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med (1990) 2.76
Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg (1994) 2.69
Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int (2007) 2.69
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg (1994) 2.59
A prospective randomized comparison of laparoscopic appendectomy with open appendectomy: Clinical and economic analyses. Surgery (2001) 2.57
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1997) 2.42
Follicular bronchitis/bronchiolitis. Hum Pathol (1985) 2.40
Primary hepatic malignancy: surgical management and determinants of survival. Surgery (1989) 2.35
Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology (1996) 2.33
Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome. Am J Respir Crit Care Med (2000) 2.30
Surgical management of unresectable carcinoma of the pancreas. Surgery (1982) 2.30
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J (1998) 2.23
Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology (2001) 2.20
Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1991) 2.04
Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc (1998) 2.04
What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03
CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol (2003) 2.01
Preoperative recognition of intestinal strangulation obstruction. Prospective evaluation of diagnostic capability. Am J Surg (1983) 1.99
The lung in inflammatory bowel disease. Medicine (Baltimore) (1993) 1.98
Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J (2000) 1.97
Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection. Hernia (2013) 1.97
The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96
Clear cell tumor of the lung. A clinicopathologic, immunohistochemical, and ultrastructural study of eight cases. Am J Surg Pathol (1990) 1.92
Hamman-Rich syndrome revisited. Mayo Clin Proc (1990) 1.92
Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg (1981) 1.90
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
The lung in inflammatory bowel disease. Eur Respir J (2000) 1.87
Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg (1994) 1.86
Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet (1989) 1.85
Lung nodule enhancement at CT: prospective findings. Radiology (1996) 1.85
Obstructive sleep apnoea and perioperative complications in bariatric patients. Br J Anaesth (2010) 1.85
Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA (1980) 1.85
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J (2003) 1.81
Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc (1990) 1.80
Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology (1995) 1.78
Immunofluorescent staining for mast cells in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc (1992) 1.77
Lymphoepithelioma-like carcinoma of the lung. Am J Surg Pathol (1989) 1.77
Pancreatic lymphoma: is it a surgical disease? Pancreas (1994) 1.77
Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74
Selected management of pancreatic pseudocysts: operative versus expectant management. Surgery (1992) 1.72
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71
Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68
The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg (2000) 1.67
Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66
Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J (2008) 1.65
Pulmonary and mediastinal glomus tumors--report of five cases including a pulmonary glomangiosarcoma: a clinicopathologic study with literature review. Am J Surg Pathol (2000) 1.64
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery (1985) 1.64
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64
Treatment of pyogenic hepatic abscesses. Surgical vs percutaneous drainage. Arch Surg (1986) 1.63
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery (2000) 1.63
Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc (1995) 1.61
Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective. World J Surg (1984) 1.61
Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol (1989) 1.60
Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis. Br J Surg (1995) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol (2000) 1.59
Spectrum and management of major complications of laparoscopic cholecystectomy. Am J Surg (1993) 1.59
Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery (1992) 1.59
Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med (2001) 1.58
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58
Mesothelial/monocytic incidental cardiac excrescences: cardiac MICE. Mod Pathol (1994) 1.58
Surgical management of hepatic hydatid disease. Mayo Clin Proc (1991) 1.57